[go: up one dir, main page]

BR0010119A - Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo - Google Patents

Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo

Info

Publication number
BR0010119A
BR0010119A BR0010119-2A BR0010119A BR0010119A BR 0010119 A BR0010119 A BR 0010119A BR 0010119 A BR0010119 A BR 0010119A BR 0010119 A BR0010119 A BR 0010119A
Authority
BR
Brazil
Prior art keywords
extract
composition
acid derivative
prevent
hydroxycinnamic acid
Prior art date
Application number
BR0010119-2A
Other languages
English (en)
Inventor
Kim
Yung Hi
Song
Dong-Keun
Suh
Hong Won
Huh
Sung Oh
Original Assignee
Scingenic Co Ltd
Byosynergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36314091&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010119(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scingenic Co Ltd, Byosynergen Inc filed Critical Scingenic Co Ltd
Publication of BR0010119A publication Critical patent/BR0010119A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"COMPOSIçãO PARA PREVENIR OU TRATAR DA DEMêNCIA CONTENDO UM DERIVADO DO áCIDO HIDROXICINâMICO OU UM EXTRATO DE UMA PLANTA DO GENUS ANGELICAE CONTENDO O MESMO". A presente invenção refere-se a uma composição caracterizada por prevenir ou tratar da demência, consistindo em um derivado do ácido hidrocinâmico da fórmula (I), decursinol, um sal aceitável farmaceuticamente a partir deste ou um extrato de uma planta do genus Angelicae contendo o mesmo, onde,
BR0010119-2A 1999-04-13 2000-04-12 Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo BR0010119A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19990013613 1999-04-13
KR19990023347 1999-06-16
PCT/KR2000/000337 WO2000061131A1 (en) 1999-04-13 2000-04-12 Composition for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus angelicae containing same

Publications (1)

Publication Number Publication Date
BR0010119A true BR0010119A (pt) 2002-04-02

Family

ID=36314091

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010119-2A BR0010119A (pt) 1999-04-13 2000-04-12 Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo

Country Status (12)

Country Link
US (2) US20050163879A1 (pt)
EP (1) EP1175208B1 (pt)
JP (1) JP4350910B2 (pt)
KR (1) KR100336182B1 (pt)
CN (1) CN1347316A (pt)
AT (1) ATE301460T1 (pt)
AU (1) AU4147800A (pt)
BR (1) BR0010119A (pt)
DE (1) DE60021873T2 (pt)
EA (1) EA005565B1 (pt)
ES (1) ES2246845T3 (pt)
WO (1) WO2000061131A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090635B1 (en) * 1999-09-22 2006-03-15 Kao Corporation Use of ferulic acid for treating hypertension
KR100397950B1 (ko) * 2000-01-24 2003-09-19 주식회사 겟웰바이오 데커시놀 또는 이의 유도체를 포함하는 진통제 조성물
KR100365649B1 (ko) * 2000-06-27 2002-12-26 학교법인고려중앙학원 항암제로서의 데커신의 유도체 및 그 합성방법
KR100365650B1 (ko) * 2000-06-27 2002-12-26 학교법인고려중앙학원 항암제 데커신 및 그 합성방법
KR100386078B1 (ko) * 2000-10-17 2003-06-02 드림바이오젠 주식회사 유화제 조성물 및 이로부터 제조된 에멀젼 연료유
KR100413963B1 (ko) * 2000-12-06 2004-01-07 주식회사 엘컴사이언스 쿠마린 유도체의 항치매제로서의 용도 및 이 화합물을유효성분으로 함유하는 약학적 제제
KR100427704B1 (ko) * 2001-09-21 2004-04-30 주식회사 겟웰바이오 데커시놀을 포함하는 살리실산염 유도체-유발성 위점막손상의 예방 및 치료용 조성물
KR20030049793A (ko) * 2001-12-17 2003-06-25 주식회사 싸이젠하베스트 당귀 추출물을 함유하는 기억력 증진용 식품 소재
KR20040023197A (ko) * 2002-09-11 2004-03-18 백일성 진피, 적복령, 당귀, 조구등, 석창포, 창출, 백지,산조인, 숙지황, 산수유, 원지를 주성분으로 함유하는치매치료의 약학적 효능
KR20040023196A (ko) * 2002-09-11 2004-03-18 백일성 진피, 적복령, 당귀, 조구등, 석창포, 창출, 백지,산조인, 숙지황, 산수유 및 원지를 주성분으로 함유하는치매치료의 의약 조성물
CN100353936C (zh) * 2003-08-07 2007-12-12 丽珠集团利民制药厂 阿魏酸钠输液及其处方和制备工艺
JP5022901B2 (ja) * 2004-09-09 2012-09-12 インダストリー−アカデミック コープレーション ファンデーション テグ ハーニ ユニバーシティ ニコチン中毒および禁断症状を予防および治療するためのオニノダケ（Ａｎｇｅｌｉｃａｇｉｇａｓ）から単離した精製エッセンシャルオイル抽出物および低級アルコール可溶性抽出物を含む組成物
WO2006080590A1 (en) * 2005-01-25 2006-08-03 University-Industry Cooperation Group Of Kyung Hee University Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases
KR100749233B1 (ko) * 2006-03-13 2007-08-13 (주)에이지아이 참당귀 추출물의 제조방법 및 그 조성물
KR100896700B1 (ko) * 2007-01-04 2009-05-14 고려대학교 산학협력단 뇌 신경세포 콜린아세틸트랜스퍼라제 활성화 기능을 갖는부추 추출물
KR101145930B1 (ko) * 2007-06-11 2012-05-15 국립암센터 클로로겐산을 포함하는 트란스글루타미나제 억제제 및 그의제조방법
MX2009008888A (es) * 2009-08-20 2009-10-14 Biokab S A De C V Metodos para acelerar el desarrollo muscular, disminuir los depositos de grasa y mejorar la eficiencia alimenticia en cerdos.
WO2012047063A2 (ko) * 2010-10-08 2012-04-12 제일약품주식회사 당귀 추출물, 은행엽 추출물 단독； 또는 당귀 추출물 및 은행엽 추출물의 혼합물을 포함하는 치매 치료보조용 또는 치매치료용 약학적 조성물
JP6257627B2 (ja) * 2013-07-30 2018-01-10 長谷川　亨 脳機能改善用組成物
DE102017127865A1 (de) * 2017-11-24 2019-05-29 Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne) Verbindung zur Anwendung bei der Steigerung von mentaler Leistungsfähigkeit
CN110833541A (zh) * 2019-08-27 2020-02-25 浙江工商大学 一种阿魏酸丁酯的制备方法及其在治疗或者预防阿兹海默症中的功能应用
CN110845594A (zh) * 2019-12-02 2020-02-28 大连海洋大学 可增强长牡蛎免疫应答的重组血清淀粉样蛋白a及制备方法
CN111018696A (zh) * 2019-12-04 2020-04-17 浙江理工大学 一种当归阿魏酸的提取方法
CN111759915A (zh) 2020-07-20 2020-10-13 南通大学 一种神经再生复方制剂及其制备方法和用途
CN114246853B (zh) * 2020-09-21 2023-08-29 北京化工大学 异阿魏酸在制备用于防治冠状病毒感染的产品中的应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068148A (en) * 1959-12-07 1962-12-11 Us Vitamin Pharm Corp Cis-cinnamic acid anti-inflammatory compositions and process of treating inflammation and capillary fragility
US4687761A (en) * 1985-05-09 1987-08-18 Yaguang Liu Pharmaceutical composition for increasing immunity and decreasing side effects of anticancer chemotherapy
US4945115A (en) * 1985-05-09 1990-07-31 Yaguang Liu Process for preparing ferulic acid
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
US4842859A (en) * 1986-09-08 1989-06-27 Yaguang Liu Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
US4906471A (en) * 1986-09-08 1990-03-06 Yaguang Liu Pharmaceutical composition for the reducing both hyperlipidemia and platelet-aggregation (PHP)
JPS63255222A (ja) * 1987-04-14 1988-10-21 Nippon Petrochem Co Ltd クマリン類からなる虚血性心疾患治療用カルシウム拮坑剤
JPS6490132A (en) * 1987-10-01 1989-04-06 Lion Corp Superoxide dismutase derivative
JP2629251B2 (ja) * 1988-03-28 1997-07-09 株式会社ツムラ 抗痴呆症剤
JPH02104568A (ja) * 1988-06-22 1990-04-17 Yoshitomi Pharmaceut Ind Ltd 神経成長因子産生促進作用剤
JPH04134028A (ja) * 1990-09-20 1992-05-07 Kanegafuchi Chem Ind Co Ltd 脳機能改善剤および抗うつ剤
JP3086728B2 (ja) * 1990-09-28 2000-09-11 鐘淵化学工業株式会社 消化性潰瘍治療または予防剤
JPH07110812B2 (ja) * 1990-12-11 1995-11-29 財団法人喫煙科学研究財団 神経成長因子生合成促進剤
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
JPH04275224A (ja) * 1991-03-02 1992-09-30 Kissei Pharmaceut Co Ltd 痴呆症治療剤
JP2971704B2 (ja) * 1993-06-30 1999-11-08 株式会社クボタ 歩行型作業機の変速操作構造
JP3490114B2 (ja) * 1993-07-09 2004-01-26 呉羽化学工業株式会社 軟骨保護剤
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
JP3665360B2 (ja) * 1994-05-02 2005-06-29 ポーラ化成工業株式会社 活性酸素消去剤及びこれを含む組成物
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5868603A (en) * 1996-12-12 1999-02-09 Corning Incorporated Method for edge finishing glass sheets
US6014038A (en) * 1997-03-21 2000-01-11 Lightspeed Semiconductor Corporation Function block architecture for gate array
JPH10295325A (ja) * 1997-04-28 1998-11-10 Katsuji Nagamitsu 健康食品
US6264994B1 (en) * 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
CN1061882C (zh) * 1997-05-29 2001-02-14 廖宣盛 一种治疗中风疾病的中药
US6524625B2 (en) * 1998-06-30 2003-02-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyuto Physiologically active extract obtained from indigo plant polygonum tinctorium
US6245634B1 (en) * 1999-10-28 2001-06-12 Easic Corporation Method for design and manufacture of semiconductors
US6331733B1 (en) * 1999-08-10 2001-12-18 Easic Corporation Semiconductor device
US6236229B1 (en) * 1999-05-13 2001-05-22 Easic Corporation Integrated circuits which employ look up tables to provide highly efficient logic cells and logic functionalities
US6194912B1 (en) * 1999-03-11 2001-02-27 Easic Corporation Integrated circuit device
US6331790B1 (en) * 2000-03-10 2001-12-18 Easic Corporation Customizable and programmable cell array
US6294927B1 (en) * 2000-06-16 2001-09-25 Chip Express (Israel) Ltd Configurable cell for customizable logic array device
US6696856B1 (en) * 2001-10-30 2004-02-24 Lightspeed Semiconductor Corporation Function block architecture with variable drive strengths

Also Published As

Publication number Publication date
JP4350910B2 (ja) 2009-10-28
EA200101077A1 (ru) 2002-04-25
EA005565B1 (ru) 2005-04-28
EP1175208A4 (en) 2003-05-21
KR100336182B1 (ko) 2002-05-10
DE60021873T2 (de) 2006-05-24
EP1175208B1 (en) 2005-08-10
US20060159790A1 (en) 2006-07-20
ATE301460T1 (de) 2005-08-15
AU4147800A (en) 2000-11-14
EP1175208A1 (en) 2002-01-30
DE60021873D1 (de) 2005-09-15
ES2246845T3 (es) 2006-03-01
US20050163879A1 (en) 2005-07-28
WO2000061131A1 (en) 2000-10-19
CN1347316A (zh) 2002-05-01
KR20000071673A (ko) 2000-11-25
JP2002541194A (ja) 2002-12-03

Similar Documents

Publication Publication Date Title
BR0010119A (pt) Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo
YU54896A (sh) (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori
GEP19960313B (en) Method for Production of Pyridin Derivatives
CA2335285A1 (en) Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
ES2185307T3 (es) Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
NO950297D0 (no) Prolinamidderivater
BG66087B1 (bg) Хинолинонови производни като тирозин киназни инхибитори
AP2002002637A0 (en) Novel piperazine
DK0567271T3 (da) Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
MY113733A (en) Salts of an anti-migraine indole derivative
BR9811099A (pt) Inibidores de urocinase
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
RU93005334A (ru) Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозиция
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
NO943895L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
NO983511L (no) Difenylstilbener som pro-legemidler til COX-2-inhibitorer
DK1165491T3 (da) LTA4-hydrolase-inhibitorer
RS50033B (sr) Derivati etansulfonil-piperidina
ES2164454T3 (es) Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.
NO20005551L (no) 2"-deoksyhygromycinderivater

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.